New shot aims to cut dangerous COPD attacks
NCT ID NCT07440524
First seen Feb 28, 2026 · Last updated May 08, 2026 · Updated 8 times
Summary
This study tests an experimental drug called JKN24011 in 215 people with moderate to severe COPD. The goal is to see if the drug can safely reduce the number of serious flare-ups compared to a placebo. Participants receive injections under the skin while continuing their usual COPD medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huadong Hospital, Fudan University
Shanghai, 200040, China
Conditions
Explore the condition pages connected to this study.